UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Phase engineering of a multiphasic 1T/2H MoS2 catalyst for highly efficient hydrogen evolution

Journal of materials chemistry. A, Materials for energy and sustainability, 2017, Vol.5 (6), p.2681-2688

2017

Link zum Volltext

Verfügbarkeit prüfen

Dose‐response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium

Pediatric blood & cancer, 2020-10, Vol.67 (10), p.e28606-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003633

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

Journal for immunotherapy of cancer, 2019-06, Vol.7 (1), p.154-154, Article 154

2019

Link zum Volltext

Verfügbarkeit prüfen

Maximum utilization of nacre-mimetic composites by architecture manipulation and interface modification towards critical damage state

Composites science and technology, 2023-03, Vol.233, p.109893, Article 109893

2023

Link zum Volltext

Verfügbarkeit prüfen

Temperature-Dependent Paracrystalline Nucleation in Atomically Disordered Diamonds

Nano letters, 2024-01, Vol.24 (1), p.312-318

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4396: A bioinformatics approach for cancer immunotherapeutic target identification by evaluating surfaceome gene and protein expression (CITIESGAPE) in tumor and pan-normal tissues

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4396-4396

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3110: ICAM-1(CD54) mediated bi-lineage differentiation in osteosarcoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3110-3110

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 932: Conditional p53 loss in chondrocytes leads to osteosarcoma in mice

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.932-932

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 82: Transforming of human osteoblasts with the combination of hTERT (T), SV40Tag (S) and c-Myc: Changes in phenotype and tumorigenesis capability

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.82-82

2019

Link zum Volltext

Verfügbarkeit prüfen

Discontinuous phase diagram of amorphous carbons

National science review, 2024-04, Vol.11 (4), p.nwae051-nwae051

2024

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium

Molecular cancer therapeutics, 2022-08, Vol.21 (8), p.1318-1325

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5932: Clonal mapping phylogenetic and transcriptomic analysis of an M36 PDX amputation lung metastatic osteosarcoma model

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5932-5932

2023

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Molecular cancer therapeutics, 2022-06, Vol.21 (6), p.903-913

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2866: Surfaceome profiling in osteosarcoma: Identification of the candidate immunotherapeutic target

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2866-2866

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1291: Notch2 inhibition as a therapeutic intervention in osteosarcoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1291-1291

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3655: Mapping the osteogenic lineage and identification of the cell of origin of osteosarcoma through high-dimensional analysis

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3655-3655

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5405: Integrative surfaceome profiling identifies MMP14, MRC2 and CD276 as candidate immunotherapeutic target in osteosarcomas

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5405-5405

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5415: Profiling cancer testis antigens in osteosarcomas

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5415-5415

2020

Link zum Volltext

Verfügbarkeit prüfen

CRS free T cell therapy: T cell membrane anchored and tumor targeted IL12 (ATTIL12)-T cell therapy eliminates large tumors, overcomes heterogeneity, and avoids adverse effects

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.239-239.1

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB008: Integrative surfaceome profiling identifies immunotherapeutic targets in osteosarcomas (OS); Preclinical testing of BT1769, an MT1-MMP-targeted Bicycle Toxin Conjugate, in OS by the Pediatric Preclinical Testing Consortium (PPTC)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB008-LB008

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase engineering of a multiphasic 1T/2H MoS2 catalyst for highly efficient hydrogen evolutionElectronic supplementary information (ESI) available: Experimental details, SEM, TEM and HRTEM images of A-1T@2H MoS2, electrochemical capacitance measurements and a summary of MoS2-based catalysts. See DOI: 10.1039/c6ta09409k

2017-02

Link zum Volltext

Verfügbarkeit prüfen

Phase engineering of a multiphasic 1T/2H MoS 2 catalyst for highly efficient hydrogen evolution

Journal of materials chemistry. A, Materials for energy and sustainability, 2017, Vol.5 (6), p.2681-2688

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3975: Clonal emergence of resistance to methotrexate in osteosarcoma barcoded PDX cells

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3975-3975

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1700: Clonal emergence of resistance to methotrexate in osteosarcoma barcoded PDX cells

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1700-1700

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Phase engineering of a multiphasic 1T/2H MoS2 catalyst for highly efficient hydrogen evolution

Dose‐response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

Maximum utilization of nacre-mimetic composites by architecture manipulation and interface modification towards critical damage state

Temperature-Dependent Paracrystalline Nucleation in Atomically Disordered Diamonds

Abstract 4396: A bioinformatics approach for cancer immunotherapeutic target identification by evaluating surfaceome gene and protein expression (CITIESGAPE) in tumor and pan-normal tissues

Abstract 3110: ICAM-1(CD54) mediated bi-lineage differentiation in osteosarcoma

Abstract 932: Conditional p53 loss in chondrocytes leads to osteosarcoma in mice

Abstract 82: Transforming of human osteoblasts with the combination of hTERT (T), SV40Tag (S) and c-Myc: Changes in phenotype and tumorigenesis capability

Discontinuous phase diagram of amorphous carbons

Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium

Abstract 5932: Clonal mapping phylogenetic and transcriptomic analysis of an M36 PDX amputation lung metastatic osteosarcoma model

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Abstract 2866: Surfaceome profiling in osteosarcoma: Identification of the candidate immunotherapeutic target

Abstract 1291: Notch2 inhibition as a therapeutic intervention in osteosarcoma

Abstract 3655: Mapping the osteogenic lineage and identification of the cell of origin of osteosarcoma through high-dimensional analysis

Abstract 5405: Integrative surfaceome profiling identifies MMP14, MRC2 and CD276 as candidate immunotherapeutic target in osteosarcomas

Abstract 5415: Profiling cancer testis antigens in osteosarcomas

CRS free T cell therapy: T cell membrane anchored and tumor targeted IL12 (ATTIL12)-T cell therapy eliminates large tumors, overcomes heterogeneity, and avoids adverse effects

Abstract LB008: Integrative surfaceome profiling identifies immunotherapeutic targets in osteosarcomas (OS); Preclinical testing of BT1769, an MT1-MMP-targeted Bicycle Toxin Conjugate, in OS by the Pediatric Preclinical Testing Consortium (PPTC)

Phase engineering of a multiphasic 1T/2H MoS 2 catalyst for highly efficient hydrogen evolution

Abstract 3975: Clonal emergence of resistance to methotrexate in osteosarcoma barcoded PDX cells

Abstract 1700: Clonal emergence of resistance to methotrexate in osteosarcoma barcoded PDX cells

Suchergebnisse filtern